marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-14-2022
LogicBio Therapeutics Balance Sheet 2011-2024 | LOGC
Annual Balance Sheet LogicBio Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-47.2 M | -60.1 M | -5.76 M | -80.9 M | -24.6 M | -1.73 M | - | - | - | - | - |
Long Term Debt |
5.01 M | 8.11 M | 9.81 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.23 M | 1.09 M | 504 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 13.1 M | 9.81 M | - | 33.1 M | 4.36 M | - | - | - | - | - |
Total Current Liabilities |
19.6 M | 6.15 M | 3.56 M | 2.68 M | - | - | - | - | - | - | - |
Total Liabilities |
32 M | 19.2 M | 13.4 M | 2.68 M | 34.8 M | 5.28 M | - | - | - | - | - |
Deferred Revenue |
10.6 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-140 M | -100 M | -67.4 M | -27.2 M | -9.62 M | -3.88 M | - | - | - | - | - |
Total Assets |
62.8 M | 80.6 M | 55.7 M | 82.9 M | 26.2 M | 2.03 M | - | - | - | - | - |
Cash and Cash Equivalents |
53.5 M | 70.1 M | 33.1 M | 80.9 M | 24.6 M | - | - | - | - | - | - |
Book Value |
30.7 M | 61.4 M | 42.3 M | 80.2 M | -8.6 M | -3.25 M | - | - | - | - | - |
Total Shareholders Equity |
30.7 M | 61.4 M | 42.3 M | 80.2 M | -8.6 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet LogicBio Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 2.63 M | 3.42 M | 4.22 M | 5.01 M | 5.79 M | 6.57 M | 7.34 M | 8.11 M | 8.11 M | 8.11 M | 8.11 M | 9.81 M | 9.81 M | 9.81 M | 9.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 22.9 M | 26.3 M | 27 M | 32 M | 29.4 M | 33.1 M | 19.7 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 2.68 M | 2.68 M | - | 2.68 M | 1.71 M | 1.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | 8.36 M | 10.4 M | 8.69 M | 10.6 M | 4.84 M | 4.84 M | - | - | - | 101 K | 1.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | -158 M | -152 M | -147 M | -140 M | -131 M | -121 M | -110 M | -100 M | -100 M | -100 M | -100 M | -67.4 M | -67.4 M | -67.4 M | -67.4 M | -27.2 M | -27.2 M | -27.2 M | -27.2 M | -9.62 M | -9.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | 38.6 M | 47 M | 51.9 M | 62.8 M | 68.2 M | 77.9 M | 73.9 M | 80.6 M | 80.6 M | 80.6 M | 80.6 M | 55.7 M | 55.7 M | 55.7 M | 55.7 M | 82.9 M | 82.9 M | 82.9 M | 82.9 M | 26.2 M | 26.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | 30.8 M | 38.8 M | 42.7 M | 53.5 M | 59.6 M | 68.1 M | 63.9 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M | 33.1 M | 33.1 M | 33.1 M | 33.1 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 24.6 M | 24.6 M | - | - | 1.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | 15.7 M | 20.7 M | 24.9 M | 30.7 M | 38.8 M | 44.8 M | 54.2 M | 61.4 M | 61.4 M | 61.4 M | 61.4 M | 42.3 M | 42.3 M | 42.3 M | 42.3 M | 80.2 M | 80.2 M | 82.9 M | 80.2 M | 24.5 M | 24.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | 15.7 M | 20.7 M | 24.9 M | 30.7 M | 38.8 M | 44.8 M | 54.2 M | 61.4 M | 61.4 M | 61.4 M | 61.4 M | 42.3 M | 42.3 M | 42.3 M | 42.3 M | 80.2 M | 80.2 M | 80.2 M | 80.2 M | -8.6 M | -8.6 M | -4.93 M | - | -3.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency